Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Pacira Biosciences Inc PCRX

Pacira BioSciences, Inc. engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension for postsurgical pain management; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension... see more

Current News (NDAQ:PCRX)

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Pacira BioSciences, Inc. (PCRX) And Encourages Stockholders to Reach Out

ACCESS Newswire 7 hours ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Pacira BioSciences, Inc. (PCRX) And Encourages Stockholders to Connect

ACCESS Newswire 3 days ago

Pacira BioSciences, Inc. (PCRX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

ACCESS Newswire 5 days ago

Pacira Announces Agreement with LG Chem to Make EXPAREL® Available in Select Asian-Pacific Markets

GlobeNewswire 5 days ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Pacira BioSciences, Inc. (PCRX) and Encourages Stockholders to Learn More About the Investigation

ACCESS Newswire 7 days ago

Pacira Reports Preliminary Unaudited Fourth Quarter and Full-Year 2025 Revenues

GlobeNewswire 10 days ago

Bronstein, Gewirtz & Grossman, LLC Encourages Pacira BioSciences, Inc. (PCRX) Investors to Inquire about Securities Investigation

ACCESS Newswire 10 days ago

Pacira BioSciences to Present at the 44th Annual J.P. Morgan Healthcare Conferences

GlobeNewswire 11 days ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Pacira BioSciences, Inc. (PCRX) And Encourages Shareholders to Connect

ACCESS Newswire January 4, 2026

Bullboard Posts (NDAQ:PCRX)

RE:Pacira BioSciences: Leading the Non-Opioid Pain Management R

Thank you for the info.
NathanGriffin - January 24, 2025

Pacira BioSciences: Leading the Non-Opioid Pain Management R

Looks like a solid play in the non-opioid pain mgmt space. PCRX has been killing it with EXPAREL, now pushing 15M patients treated. Q3...
MikeTester - January 24, 2025

Podcasts